Ledipasvir/sofosbuvirDevelopment of resistance in hepatitis C virus infection genotype 4d: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2018年 / 1722卷 / 1期
关键词：
D O I：
10.1007/s40278-018-52531-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：202 / 202
相关论文
共 50 条
  • [21] Ribavirin/sofosbuvirDevelopment of viral breakthrough in chronic hepatitis C: case report
    [J]. Reactions Weekly, 2018, 1692 (1) : 312 - 312
  • [22] Ledipasvir-sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection
    Asahina, Yasuhiro
    Itoh, Yoshito
    Ueno, Yoshiyuki
    Matsuzaki, Yasushi
    Takikawa, Yasuhiro
    Yatsuhashi, Hiroshi
    Genda, Takuya
    Ikeda, Fusao
    Matsuda, Takuma
    Dvory-Sobol, Hadas
    Jiang, Deyuan
    Massetto, Benedetta
    Osinusi, Anu O.
    Brainard, Diana M.
    McHutchison, John G.
    Kawada, Norifumi
    Enomoto, Nobuyuki
    [J]. LIVER INTERNATIONAL, 2018, 38 (09) : 1552 - 1561
  • [23] Eight Weeks of Ledipasvir/Sofosbuvir Is Effective for Selected Patients With Genotype 1 Hepatitis C Virus Infection
    Kowdley, Kris V.
    Sundaram, Vinay
    Jeon, Christie Y.
    Qureshi, Kamran
    Latt, Nyan L.
    Sahota, Amandeep
    Lott, Stephen
    Curry, Michael P.
    Tsai, Naoky
    Chaiyakunapruk, Nathorn
    Lee, Yoori
    Petersen, Jorg
    Buggisch, Peter
    [J]. HEPATOLOGY, 2017, 65 (04) : 1094 - 1103
  • [24] Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection
    Dietz, Julia
    Kalinina, Olga, V
    Vermehren, Johannes
    Peiffer, Kai-Henrik
    Matschenz, Katrin
    Buggisch, Peter
    Niederau, Claus
    Schattenberg, Jorn M.
    Muellhaupt, Beat
    Yerly, Sabine
    Ringelhan, Marc
    Schmid, Roland M.
    Antoni, Christoph
    Mueller, Tobias
    zur Wiesch, Julian Schulze
    Piecha, Felix
    Moradpour, Darius
    Deterding, Katja
    Wedemeyer, Heiner
    Moreno, Christophe
    Berg, Thomas
    Berg, Christoph P.
    Zeuzem, Stefan
    Welsch, Christoph
    Sarrazin, Christoph
    [J]. JOURNAL OF VIRAL HEPATITIS, 2020, 27 (10) : 974 - 986
  • [25] Ledipasvir/sofosbuvir/vonoprazanRecurrence of hepatitis C virus secondary to treatment failure: case report
    [J]. Reactions Weekly, 2016, 1630 (1) : 154 - 154
  • [26] Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection
    Einsiedel, Hagen Graf
    Christiansen, Holger
    Wiegand, Johannes
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (12) : 1373 - 1373
  • [27] The Effectiveness of Ledipasvir/Sofosbuvir in Youth With Genotype 4 Hepatitis C Virus A Single Egyptian Center Study
    Fouad, Hanan Mina
    Mohamed, Amal Ahmed
    Sabry, Magda
    Aziz, Hossam Abdel
    Eysa, Basem
    Rabea, Mohamed
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (01) : 22 - 25
  • [28] Ledipasvir-Sofosbuvir for the treatment of Hepatitis C Virus Genotype 1 and 4 Post Renal Transplantation
    Abaalkhail, Faisal A.
    Al-Hamoudi, Waleed K.
    Al Sebayel, Mohammed
    Aljedai, Ahmed
    Elbeshbeshy, Hany
    Ajlan, Aziza A.
    Elsiesy, Hussein A.
    [J]. HEPATOLOGY, 2016, 64 : 980A - 980A
  • [29] Enhanced virological responses in genotype 4 hepatitis C virus infection: a case control study
    Yan, K.
    George, J.
    Freiman, J.
    Craig, P.
    Hui, J.
    Zekry, A.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A308 - A308
  • [30] EtanerceptExacerbation of hepatitis C virus infection: case report
    [J]. Reactions Weekly, 1999, 761 (1) : 8 - 8
12345